Aquatic Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Aquatic Capital Management’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-800	Closed	-$5K	–	1898
2022 Q3	$5K	Buy	800 +790	+7,900%	+$6.42K	﹤0.01%	1093
2022 Q2	$0	Sell	10 -530	-98%	-$4.96K	﹤0.01%	1638
2022 Q1	$6K	Buy	540 +350	+184%	+$6.26K	0.01%	805
2021 Q4	$6K	Buy	+190	New	+$7.69K	0.01%	923

Other funds holding SYRS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Aquatic Capital Management's SYRS Position: Q4 2022 in Review

Aquatic Capital Management sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q4 2022, closing a stake of 800 shares — an estimated $5K sold.

Aquatic Capital Management first reported a position in SYRS in Q4 2021 and held it in 4 quarters. The position peaked at $6K in Q1 2022. 57 funds tracked by Wall St. Rank hold SYRS as of Q4 2022.

Aquatic Capital Management reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Aquatic Capital Management sold 800 Syros Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $5K.
Aquatic Capital Management first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Aquatic Capital Management's Syros Pharmaceuticals, Inc. Common Stock position peaked at $6K in Q1 2022.
57 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Aquatic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.